scholarly journals Maternal and Neonatal Effects of Vasopressors Used for Treating Hypotension after Spinal Anesthesia for Caesarean Section: A Randomized Controlled Study

2015 ◽  
Vol 4 (1) ◽  
pp. 54-58 ◽  
Author(s):  
Alma Soxhuku-Isufi ◽  
Vjollca Shpata ◽  
Hektor Sula
Keyword(s):  
Caesarean Section ◽  
Pregnant Women ◽  
Spinal Anesthesia ◽  
Apgar Score ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Double Blind ◽  
Randomized Controlled ◽  
Significant Difference ◽  
Acid Base Status

AIM: The aim of the study was to examine whether ephedrine and phenylephrine were different in their efficacy for managing maternal hypotension and their effect of adverse maternal and neonatal outcome.METHODS: A double-blind randomized controlled study in healthy pregnant women ASA physical status 2, which underwent elective caesarian delivery under spinal anesthesia. Patients were randomized to receive an intravenous bolus of either phenylephrine (Ph group) or ephedrine (E group) immediately after the episode of hypotension after spinal anesthesia. Maternal and neonatal outcomes were recorded.RESULTS: Two hundred and two (202) pregnant women at term were entered in this study. There were no differences between group E and group Ph regarding the incidence of hypotension after vasopressor therapy, and the incidence of nausea and vomiting. There was no significant difference between groups in the first-minute and the 5th minute Apgar score, none of the neonates had the true fetal acidosis.CONCLUSIONS: Ephedrine and phenylephrine have the same efficacy in treating hypotension after spinal anesthesia for caesarean section. The use of Phenylephrine was associated with better fetal acid-base status, and there were no differences on Apgar score values and on the incidence of maternal bradycardia and hypotension.

scholarly journals The effect of virtual reality glasses on anxiety during surgery under spinal anesthesia: a randomized controlled study

2021 ◽  
Vol 25 (2) ◽  
Author(s):  
Ayse Zeynep Turan ◽  
Mehmet Yilmaz ◽  
Tolga Saracoglu
Keyword(s):  
Virtual Reality ◽  
Spinal Anesthesia ◽  
Trait Anxiety ◽  
Randomized Controlled Study ◽  
Controlled Study ◽  
Care Group ◽  
Control Group ◽  
State Trait Anxiety Inventory ◽  
Randomized Controlled ◽  
Significant Difference

Background & objectives: Surgery–related anxiety can be observed due to several factors in patients undergoing surgery. With developing technology virtual reality (VR) glasses have begun to be used to reduce anxiety in the preoperative period. We aimed to investigate the effect of using VR glasses on operation anxiety and sedation requirement in patients during operation under spinal anesthesia.    Methodology: We enrolled 97 patients between 18–75 y of age, ASA class I–II, in this study. Participants were randomized into VR glasses group or the standard care group. The State-Trait Anxiety Inventory for Trait Anxiety (STAI–TA) and State-Trait Anxiety Inventory for State Anxiety (STAI–SA) scores preoperatively and anxiety score on VAS scale during surgery were obtained. Patients watched a movie via VR glasses (BOBO® VR Z4) after spinal anesthesia and the surgical operation was commenced thereafter. In the control group, the surgery was begun without any additional procedure. Results: Both groups were similar in terms of demographic and hemodynamic data. There was no statistically significant difference between groups in terms of preoperative anxiety levels, STAI–SA and STAI–TA scores. However, the VAS and relative risk (RR) values were significantly lower in the study group in all measurements (p < 0.05). Conclusion: We believe that the use of VR glasses decreases perioperative anxiety and sedation requirements in patients undergoing a surgical procedure under spinal anesthesia. Key words: Spinal Anesthesia; Virtual Reality; Anxiety; Sedation Citation: Turan AZ, Yilmaz M, Saracoglu T. The effect of virtual reality glasses on anxiety during surgery under spinal anesthesia: a randomized controlled study. Anaesth pain intensive care 2021;25(2):170-175. DOI: 10.35975/apic.v25i2.1469 Received: 31 January 2021, Reviewed: 22, 25 February 2021, Accepted: 27 February 2021

Sign in / Sign up

Export Citation Format

Share Document